March 14, 2024 | By Michelle Jones | Clinical Research, Clinical Trials, Liver, Liver Disease, Liver Health, NASH, News & Events
Today, we’re talking about some exciting news for people battling fatty liver disease, specifically Nonalcoholic Steatohepatitis (NASH) a condition where too much fat is stored in the liver, causing inflammation and damage. NASH is a tricky disease because it’s often …
March 14, 2024 | By Michelle Jones | News & Events, Clinical Trials, Liver, Liver Disease, Liver Health, NASH | Promising Advance in Treatment, resmetirom, Rezdiffra
Nonalcoholic Steatohepatitis (NASH) (now known as Metabolic Dysfunction-Associated Steatohepatitis or MASH) represents a significant and growing challenge in clinical practice, with its progression to cirrhosis and hepatocellular carcinoma posing serious risks for patients. The exciting new conditional commercial launch of …
June 15, 2023 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease, Liver Health, Volunteering in Research | Cirrhosis, Clinical research, Clinical trials, Fatty Liver Disease, liver health, Liver research, Liver Scarring
Liver cirrhosis is a chronic and potentially life-threatening condition affecting many worldwide and in Arizona. Historically, men have been disproportionately affected by liver cirrhosis. Studies show that death rates amongst men with liver cirrhosis are twice as high as women. …
May 19, 2023 | By John Raslavsky | Liver, Liver Disease | Alcohol-related Liver Disease, Fibroscan, liver health, Women's Liver Health
May is Women’s Health Awareness Month, and it’s more important than ever to address the alarming rise of alcohol-related liver disease in young women. Let’s work together to empower women to make informed decisions regarding their liver health. Read our …
April 13, 2023 | By John Raslavsky | Liver, Liver Disease | Blog, Clinical research, CT Scan, Fatty Liver Disease, Fibroscan, liver health, MRI
Have you ever wondered how well your liver is functioning? Our latest blog gives you the inside scoop on the 3 most common liver scans. Learn more about what they are, how they work, and who can benefit from them! …
December 23, 2022 | By John Raslavsky | Liver, Liver Disease, Liver Health
The holiday season is finally upon us, which means it’s time for yummy foods and tasty alcoholic beverages. Many go into this season with a stress-free attitude over the food and drinks they consume. However, they aren’t considering the …
October 14, 2022 | By John Raslavsky | Liver Disease, Liver Health | Blog, Clinical research, Fatty Liver Disease, Liver research
Worldwide, liver cancer is the second most common cause of cancer-related death. Yet, with such prevalence, it remains challenging to treat. As numbers continue to rise, the value of liver research is critical to public health. Learn more about …
April 7, 2022 | By John Raslavsky | Clinical Trials, Liver Disease, Minority Participation in Liver Research | Blog, Diversity in research, Fatty Liver Disease, NAFLD, NASH, National Minority Health Month
April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that affect people from racial and ethnic minority groups. Liver disease is growing in prevalence in the Hispanic population. It is also a leading cause …
March 7, 2022 | By John Raslavsky | Fibroscan, Liver Disease | Blog, NAFLD, NASH, Women's History Month
March is Women’s History Month, and it commemorates women’s contributions to history, culture, and society. The 2022 theme is “Women Providing Healing, Promoting Hope.” It is a tribute to the countless ways women of all cultures provide healing and hope …
August 26, 2021 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease | Blog, NAFLD, NASH
Cirrhosis is when the permanent scarring of the liver has replaced the healthy tissue. While cirrhosis is most often associated with chronic alcohol consumption, it is brought about by many types of liver disease. Here’s how you get from liver disease …